Fares-Alexander Alken

Fares-Alexander Alken

Auto-generated profile, based on publicly available information

Fares-Alexander Alken

Division of Cardiology, Angiology, Intensive Care Medicine, EVK Düsseldorf, cNEP, cardiac Neuro-and Electrophysiology Research Consortium, Düsseldorf, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2021 in EP Europace
Verified
Journal Article
Closed access
PDF file
AKAnn-Kathrin Kahle
Ann-Kathrin Kahle
CJChristiane Jungen
Christiane Jungen
FAFares-Alexander Alken
Fares-Alexander Alken
KSKatharina Scherschel
Katharina Scherschel
SWStephan Willems
Stephan Willems
CMChristian Meyer
Christian Meyer
Worldwide, ∼4 million people die from sudden cardiac death every year caused in more than half of the cases by ischaemic cardiomyopathy (ICM). Prevention of sudden cardiac death after myocardial infarction by implantation of a cardioverter-defibrillator (ICD) is the most common, even though not curative, therapy to date. Optimized ICD programming should be strived for in order to decrease the incidence of ICD interventions. Catheter ablation reduces the recurrence of ventricular tachycardias (VTs) and is an important adjunct to sole ICD-based treatment or pharmacological antiarrhythmic therapy in patients with ICM, as conclusively demonstrated by seven randomized controlled trials (RCTs) in the last two decades. However, none of the conducted trials was powered to reveal a survival benefit for ablated patients as compared to controls. Whereas thorough consideration of an early approach is necessary following two recent RCTs (PAUSE-SCD, BERLIN VT), catheter ablation is particularly recommended in patients with recurrent VT after ICD therapy. In this context, novel, pathophysiologically driven ablation strategies referring to deep morphological and functional substrate phenotyping based on high-resolution mapping and three-dimensional visualization of scars appear promising. Emerging concepts like sympathetic cardiac denervation as well as radioablation might expand the therapeutical armamentarium especially in patients with therapy-refractory VT. Randomized controlled trials are warranted and on the way to investigate how these translate into improved patient outcome. This review summarizes therapeutic strategies currently available for the prevention of VT recurrences, the optimal timing of applicability, and highlights future perspectives after a PAUSE in BERLIN.

6 July 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
AKAnn-Kathrin Kahle
Ann-Kathrin Kahle
RGRoberto G. Gallotti
Roberto G. Gallotti
FAFares‐Alexander Alken
Fares‐Alexander Alken
CMChristian Meyer
Christian Meyer
JMJeremy P. Moore
Jeremy P. Moore
Background: Ultra‐high‐density mapping enables detailed mechanistic analysis of atrial reentrant tachycardia but has yet to be used to assess circuit conduction velocity (CV) patterns in adults with congenital heart disease. Methods and Results: Circuit pathways and central isthmus CVs were calculated from consecutive ultra‐high‐density isochronal maps at 2 tertiary centers over a 3‐year period. Circuits using anatomic versus surgical obstacles were considered separately and pathway length <50th percentile identified small circuits. CV analysis was used to derive a novel index for prediction of postablation conduction block. A total of 136 supraventricular tachycardias were studied (60% intra‐atrial reentrant, 14% multiple loop). Circuits with anatomic versus surgical obstacles featured longer pathway length (119 mm; interquartile range [IQR], 80–150 versus 78 mm; IQR, 63–95; P <0.001), faster central isthmus CV (0.1 m/s; IQR, 0.06–0.25 versus 0.07 m/s; IQR, 0.05–0.10; P =0.016), faster non‐isthmus CV (0.52 m/s; IQR, 0.33–0.71 versus 0.38 m/s; IQR, 0.27–0.46; P =0.009), and fewer slow isochrones (4; IQR, 2.3–6.8 versus 6; IQR 5–7; P =0.008). Both central isthmus ( R 2 =0.45; P <0.001) and non‐isthmus CV ( R 2 =0.71; P <0.001) correlated with pathway length, whereas central isthmus CV <0.15 m/s was ubiquitous for small circuits. Non‐isthmus CV in tachycardia correlated with CV during block validation ( R 2 =0.94; P 85% predicted isthmus block in all cases. Over >1 year of follow‐up, arrhythmia‐free survival was better for homogeneous CV patterns (90% versus 57%; P =0.04). Conclusions: Ultra‐high‐density mapping‐guided CV analysis distinguishes atrial reentrant patterns in adults with congenital heart disease with surgical obstacles producing slower and smaller circuits. Very slow central isthmus CV may be essential for atrial tachycardia maintenance in small circuits, and non‐isthmus conduction time in tachycardia appears to be useful for rapid assessment of postablation conduction block.

1 June 2022 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
AKAnn-Kathrin Kahle
Ann-Kathrin Kahle
CJChristiane Jungen
Christiane Jungen
KSKatharina Scherschel
Katharina Scherschel
FAFares-Alexander Alken
Fares-Alexander Alken
CMChristian Meyer
Christian Meyer

15 June 2022 in Autonomic Neuroscience
Verified
Journal Article
Closed access
KAKatharina Apelt-Glitz
Katharina Apelt-Glitz
FAFares-Alexander Alken
Fares-Alexander Alken
CJChristiane Jungen
Christiane Jungen
KSKatharina Scherschel
Katharina Scherschel
NKNikolaj Klöcker
Nikolaj Klöcker
CMChristian Meyer
Christian Meyer

1 July 2020 in Future Cardiology
Verified
Journal Article
Open access
FAFares-Alexander Alken
Fares-Alexander Alken
SCShaojie Chen
Shaojie Chen
MMMustafa Masjedi
Mustafa Masjedi
HPHelmut Pürerfellner
Helmut Pürerfellner
PMPhilippe Maury
Philippe Maury
CMChristian Meyer
Christian Meyer
Aim: Ultra-high-density mapping (HDM) is increasingly used for guidance of catheter ablation in cardiac arrhythmias. While initial results are promising, a systematic evaluation of long-term outcom...

15 September 2023 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
AKAnn-Kathrin Kahle
Ann-Kathrin Kahle
FAFares-Alexander Alken
Fares-Alexander Alken
KSKatharina Scherschel
Katharina Scherschel
CMChristian Meyer
Christian Meyer